General Information of Drug (ID: DM3MH2H)

Drug Name
ALMB-0166
Indication
Disease Entry ICD 11 Status REF
Spinal cord injury ND51.2 Phase 1 [1]
Cross-matching ID
TTD ID
DJR71Z

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Gap junction alpha-1 protein (GJA1) TT4F7SL CXA1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05524103) A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of AlaMab Therapeutics